Chronic NOS inhibition accelerates NAFLD progression in an obese rat model

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 308, Issue 6, 2015, Pages G540-G549

  Sheldon, Ryan D ^a,b   Padilla, Jaume ^b,c   Jenkins, Nathan T ^e   Laughlin, M Harold ^c,d   Rector, R Scott ^a,b,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Missouri   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

^e UNIVERSITY OF GEORGIA   (United States)

Author keywords

Liver; N ^{< sup> nitro L arginine methyl ester; Nitric oxide; Obese Otsuka Long Evans Tokushima fatty rat}

Indexed keywords

ANTIGEN; CD163 ANTIGEN; CD206 ANTIGEN; DRINKING WATER; GLYCOPROTEIN P 15095; INSULIN; INTERLEUKIN 1BETA; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; AUTACOID; ENZYME INHIBITOR; LIPID; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; FOOD INTAKE; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEUKOCYTE ADHERENCE; LIVER FIBROSIS; LIVER INJURY; LONG EVANS TOKUSHIMA OTSUKA RAT; MACROPHAGE; MITOCHONDRIAL RESPIRATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RAT MODEL; TRIACYLGLYCEROL BLOOD LEVEL; ADAPTATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; COMPLICATION; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; EATING; ENZYMOLOGY; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER MITOCHONDRION; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; TIME;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; DISEASE PROGRESSION; DRUG-INDUCED LIVER INJURY; EATING; ENZYME INHIBITORS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; LIPIDS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MACROPHAGES; MITOCHONDRIA, LIVER; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RATS, INBRED OLETF; TIME FACTORS;

EID: 84929581933     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00247.2014     Document Type: Article

References (38)

1. Almeida A, Moncada S, Bolaños JP. Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway. Nat Cell Biol 6: 45-51, 2004.
2. Bass A, Brdiczka D, Eyer P, Hofer S, Pette D. Metabolic differentiation of distinct muscle types at the level of enzymatic organization. Eur J Biochem 10: 198-206, 1969.
3. Brown GC. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 369: 136-139, 1995.
4. Brown GC. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta 1504: 46-57, 2001.
5. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, Kemp BE. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443: 285-289, 1999.
6. Clementi E, Nisoli E. Nitric oxide and mitochondrial biogenesis: a key to long-term regulation of cellular metabolism. Comp Biochem Physiol A Mol Integr Physiol 142: 102-110, 2005.
7. Fletcher JA, Meers GM, Linden MA, Kearney ML, Morris EM, Thyfault JP, Rector RS. Impact of various exercise modalities on hepatic mitochondrial function. Med Sci Sports Exerc 46: 1089-1097, 2014.
8. Hurt KJ, Musicki B, Palese MA, Crone JK, Becker RE, Moriarity JL, Snyder SH, Burnett AL. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc Natl Acad Sci USA 99: 4061-4066, 2002.
9. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 90: 21-28, 2002.
10. Kim YM, Bergonia H, Lancaster JR Jr. Nitrogen oxide-induced autoprotection in isolated rat hepatocytes. FEBS Lett 374: 228-232, 1995.
11. Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416: 15-18, 1997.
12. Lambert A, Brand M. Superoxide production by NADH: ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane. Biochem J 382: 511-517, 2004.
13. Mason MG, Nicholls P, Wilson MT, Cooper CE. Nitric oxide inhibition of respiration involves both competitive (heme) and noncompetitive (copper) binding to cytochrome c oxidase. Proc Natl Acad Sci USA 103: 708-713, 2006.
14. McAllister RM, Newcomer SC, Pope ER, Turk JR, Laughlin MH. Effects of chronic nitric oxide synthase inhibition on responses to acute exercise in swine. J Appl Physiol 104: 186-197, 2008.
15. Minamiyama Y, Bito Y, Takemura S, Takahashi Y, Kodai S, Mizuguchi S, Nishikawa Y, Suehiro S, Okada S. Calorie restriction improves cardiovascular risk factors via reduction of mitochondrial reactive oxygen species in type II diabetic rats. J Pharmacol Exp Ther 320: 535-543, 2007.
16. Montagnani M, Chen H, Barr VA, Quon MJ. Insulin-stimulated activation of eNOS is independent of Ca2+but requires phosphorylation by Akt at Ser1179. J Biol Chem 276: 30392-30398, 2001.
17. Navarro J, Sanchez A, Saiz J, Ruilope L, Garcia-Estan J, Romero J, Moncada S, Lahera V. Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol Regul Integr Comp Physiol 267: R1516-R1521, 1994.
18. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299: 896-899, 2003.
19. Okauchi N, Mizuno A, Yoshimoto S, Zhu M, Sano T, Shima K. Is caloric restriction effective in preventing diabetes mellitus in the Otsuka Long Evans Tokushima fatty rat, a model of spontaneous non-insulindependent diabetes mellitus? Diabetes Res Clin Pract 27: 97-106, 1995.
20. Ou J, Carlos TM, Watkins SC, Saavedra JE, Keefer LK, Kim YM, Harbrecht BG, Billiar TR. Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia. Nitric Oxide Biol Chem 1: 404-416, 1997.
21. Padilla J, Jenkins NT, Thorne PK, Lansford KA, Fleming NJ, Bayless DS, Sheldon RD, Rector RS, Laughlin MH. Differential regulation of adipose tissue and vascular inflammatory gene expression by chronic systemic inhibition of NOS in lean and obese rats. Physiol Rep 2: e00225, 2014.
22. Park SY, Choi GH, Choi HI, Ryu J, Jung CY, Lee W. Calorie restriction improves whole-body glucose disposal and insulin resistance in association with the increased adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima fatty rats. Arch Biochem Biophys 436: 276-284, 2005.
23. Pasarín M, Abraldes JG, Rodríguez-Vilarrupla A, La Mura V, García-Pagán JC, Bosch J. Insulin resistance and liver microcirculation in a rat model of early NAFLD. J Hepatol 55: 1095-1102, 2011.
24. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8: 301-309, 2008.
25. Pérez-Carreras M, Del Hoyo P, Martín MA, Rubio JC, Martín A, Castellano G, Colina F, Arenas J, Solis-Herruzo JA. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38: 999-1007, 2003.
26. Rector RS, Thyfault JP, Morris RT, Laye MJ, Borengasser SJ, Booth FW, Ibdah JA. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima fatty rats. Am J Physiol Gastrointest Liver Physiol 294: G619-G626, 2008.
27. Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW, Ibdah JA. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 52: 727-736, 2010.
28. Rector RS, Thyfault JP, Wei Y, Ibdah JA. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 14: 185-192, 2008.
29. Rector RS, Uptergrove GM, Morris EM, Borengasser SJ, Laughlin MH, Booth FW, Thyfault JP, Ibdah JA. Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model. Am J Physiol Gastrointest Liver Physiol 300: G874-G883, 2011.
30. Shah V, Haddad FG, Garcia-Cardena G, Frangos JA, Mennone A, Groszmann RJ, Sessa WC. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest 100: 2923-2930, 1997.
31. Sheldon RD, Laughlin MH, Rector RS. Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats. J Appl Physiol 116: 1156-1164, 2014.
32. Srere P. Citrate synthase. Methods Enzymol 13: 3-5, 1969.
33. Stepanova M, Rafiq N, Makhlouf H, Agrawal R, Kaur I, Younoszai Z, McCullough A, Goodman Z, Younossi ZM. Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD). Dig Dis Sci 58: 3017-3023, 2013.
34. Tateya S, Rizzo-De Leon N, Handa P, Cheng AM, Morgan-Stevenson V, Ogimoto K, Kanter JE, Bornfeldt KE, Daum G, Clowes AW. VASP increases hepatic fatty acid oxidation by activating AMPK in mice. Diabetes 62: 1913-1922, 2013.
35. Tateya S, Rizzo NO, Handa P, Cheng AM, Morgan-Stevenson V, Daum G, Clowes AW, Morton GJ, Schwartz MW, Kim F. Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding. Diabetes 60: 2792-2801, 2011.
36. Tsuchiya K, Sakai H, Suzuki N, Iwashima F, Yoshimoto T, Shichiri M, Hirata Y. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice. Endocrinology 148: 4548-4556, 2007.
37. Xie G, Wang X, Wang L, Wang L, Atkinson RD, Kanel GC, Gaarde WA, DeLeve LD. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats. Gastroenterology 142: 918-927, 2012.
38. Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9: 524-530, 2011.